A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Clinical trial NCT03604224 · COMPLETED
Trial details
- NCT number
- NCT03604224
- Sponsor
- Johnson & Johnson Private Limited
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-05
- Primary completion
- 2019-07-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.